γ-Glutamyl hydrolase from human sarcoma HT-1080 cells: Characterization and inhibition by glutamine antagonists

Molecular Pharmacology

Volumn 51, Issue 5, 1997, Pages 825-832

  Waltham, Mark C ^a   Li, Wei Wei ^a   Gritsman, Helena ^a   Tong, William P ^a   Bertino, Joseph R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 DIAZO 5 OXONORLEUCINE; ACIVICIN; AZASERINE; GAMMA GLUTAMYL HYDROLASE; METHOTREXATE; TRITIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FIBROSARCOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030997685     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.5.825     Document Type: Article

References (41)

1. Allegra, C. J. Antifolates, in Cancer Chemotherapy, Principles, and Practice (B. A. Chabner and I. M. Collins, eds.). J. B. Lippincott, Philadelphia, 110-153 (1990).
2. McGuire, J. J., and J. K. Coward. Pteroylpolyglutamates: biosynthesis degradation and function, in Folates and Pterins (R. L. Blakley and S. J. Benkovic, eds.). Wiley Interscience, New York, 135-190 (1990).
3. Bertino, J. R. Karnofsky Memorial Lecture: ode to methotrexate. J. Clin. Oncol. 11:5-14 (1993).
4. Barrueco, J. R., and F. M. Sirotnak. Evidence for the facilitated transport of methotrexate polyglutamates into lysosomes derived from S180 Cells. J. Biol. Chem. 266:11732-11737 (1991).
5. Garrow, T. A., and B. Shane. Purification and general properties of human folylpolyglutamate synthetase. Adv. Exp. Med. Biol. 338:659-662 (1993).
6. Garrow, T. A., A. Admon, and B. Shane. Expression cloning of a human cDNA encoding folylpoly (γ-glutamate) synthetase and determination of its primary structure. Proc. Natl. Acad. Sci. USA 89:9151-9155 (1992).
7. Roy, K., K. Mitsugi, S. Sirlin, B. Shane, and F. M. Sirotnak. Different antifolate-resistant L1210 cell variants with either increased or decreased folylpolyglutamate synthetase gene expression at the level of mRNA transcription. J. Biol. Chem. 270:26918-26922 (1995).
8. Yao, R., Z. Nimec, T. J. Ryan, and J. Galivan. Identification, cloning, and sequencing of a cDNA coding for rat γ-glutamyl hydrolase. J. Biol. Chem. 271:8525-8528 (1996).
9. Priest, D. G., C. D. Veronee, M. Mangum, J. M. Bednarek, and M. T. Doig. Comparison of folylpolyglutamate hydrolases of mouse liver, kidney, muscle and brain. Mol. Cell. Biochem. 43:81-87 (1982).
10. Wang, T. Y., C. J. Chandler, and C. H. Halsted. Intercellular pteroylpolyglutamate hydrolase from human jejunal mucosa: isolation and characterization. J. Biol. Chem. 261:13551-13555 (1986).
11. Samuels, L. L., L. J. Goutas, D. G. Priest, J. R. Piper, and F. M. Sirotnak. Hydrolytic cleavage of methotrexate γ-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse. Cancer Res. 46:2230-2235 (1986).
12. Silink, M., R. Reddel, M. Bethel, and P. B. Rowe. γ-Glutamyl hydrolase (conjugase) purification and properties of the bovine hepatic enzyme. J. Biol. Chem. 250:5982-5994 (1975).
13. Elsenhans, B., O. Ahmad, and I. Rosenberg. Isolation and characterization of pteroylpolyglutamate hydrolase from rat intestinal mucosa. J. Biol. Chem. 259:6364-6368 (1984).
14. Chandler, C. J., T. T. Y. Wang, and C. H. Halsted. Pteroylpolyglutamate hydrolase from human jejunal brush borders: purification and characterization. J. Biol. Chem. 261:928-933 (1986).
15. Silink, M., and P. B. Rowe. The location of glutamate carboxypeptidase in rat liver lysosomes. Biochim. Biophys. Acta 381:28-36 (1975).
16. Galivan, J., T. Johnson, M. Rhee, J. McGuire, D. Priest, and V. Vesevan. The role of folylpolyglutamate synthetase and γ-glutamylhydrolase in altering cellular folyl-and antifolylpolyglutamates. Adv. Enzyme Regul. 26:147-155 (1987).
17. Kalman, T. J. Polyglutamylation of folates and antifolates as a target of chemotherapy, in Pharmacology and Therapeutics: Molecular Aspects of Chemotherapy (E. Borowski and D. Shugar, eds.). Plenum Press, New York, 139-297 (1990).
18. Baugh, C. M., and C. L. Krumdieck. Naturally occurring folates. Ann. N. Y. Acad. Sci. 186:7-28 (1971).
19. O'Connor, B., R. Rotundo, Z. Nimec, J. McGuire, and J. Galivan. Secretion of γ-glutamyl hydrolase in vitro. Cancer Res. 51:3874-3881 (1991).
20. Goker, E., M. Waltham, A. Kheradpour, T. Trippett, M. Mazumdar, Y. Elisseyeff, B. Schnieders, P. Steinherz, C. Tan, E. Berman, and J. R. Bertino, Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutation. Blood 86:677-684 (1995).
21. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. Evaluation of a soluble tetrazolium/formazin assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833 (1988).
22. Ellis, K. J., and J. F. Morrison. Buffers of constant Ionic strength for studying pH-dependent processes. Methods Enzymol. 87:405-426 (1982).
23. Waltham, M. C., S. Lin, W.-W. Li, E. Goker, H. Gritsman, W. P. Tong, and J. R. Bertino. Capillary electrophoresis of methotrexate polyglutamates and its application in evaluation of γ-glutamyl hydrolase activity. J. Chromatogr., in press.
24. Hall, C. W., I. Liebaers, P. Di Natale, and E. F. Neufeld. Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol. 50:439-456 (1978).
25. Duggleby, R. G. Regression analysis of nonlinear arrhenius plot: an empirical model and a computer program. Comput. Biol. Med. 14:447-455 (1984).
26. Lin, J. T., W. P. Tong, T. M. Trippett, D. Niedzwiecki, Y. Tao, C. Tan, P. Steinherz, B. I. Schweitzer, and J. R. Bertino. Basis for natural resistance to methotrexate in human acute non-lymphoblastic leukemia. Leuk. Res. 15:1191-1196 (1991).
27. Deleted in proof.
28. Li, W. W., M. Waltham, W. Tong, B. I. Schweitzer, and J. R. Bertino. Increased activity of γ-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate (MTX). Adv. Exp. Med. Biol. 388:536-638 (1993).
29. Rhee, M. S., T. J. Ryan, and J. H. Galivan. γ-Glutamyl hydrolase from human tumor cell lines. Cell. Pharmacol. 2:289-292 (1995).
30. Gonzalez-Noriega, A., J. Grubb, V. Talkad, and W. Sly. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal secretion by impairing receptor recycling. J. Cell. Biol. 85:839-852 (1980).
31. Hasilik, A., and E. F. Nenfeld. Biosynthesis of lysosomal enzymes in fibroblasts. J. Biol. Chem. 255:4937-4945 (1980).
32. Baugh, C., J. Stevens, and C. Krumdieck. Studies on γ-glutamyl carboxypeptidase. Biochem. Biophys. Acta 212:116-125 (1970).
33. Saini, P., and I. Rosenberg. Isolation of pteroyl-γ-oligoglutamyl endopeptidase from chicken intestine with the aid of affinity chromatography. J. Biol. Chem. 249:5131-5134 (1974).
34. Bavetsias, V., A. L. Jackman, R. Kimbell, W. Gibson, F. T. Boyle, and G. M. F. Bisset. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583). J. Med. Chem. 39:73-85 (1996).
35. Kalman, T. I., V. K. Nayak, and A. R. V. Reddy. Selective inhibition of bacterial carboxypeptidase G and pancreatic conjugase by 2-mercaptomethylglutaric acid, in Chemistry and Biology of Pteridines (B. A. Cooper and V. M. Whitehead, eds.). W. de Gruyter, Berlin, 583-586 (1986).
36. Meister, A. Metabolism and function of glutathione, in Glutathione: Chemical, Biochemical and Medical Aspects: Part A (D. Dolphin., R. Poulson, and O. Avramovic, eds.). John Wiley & Sons, New Yrok, 367-474 (1989).
37. Lyons, S. D., M. E. Sant, and R. I. Christopherson. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia. J. Biol. Chem. 265: 11377-11381 (1990).
38. Rhee, M. S., Y. Wang, M. G. Nair, and J. Galivan. Acquisition of resistance to antifolates caused by enhanced γ-glutamyl hydrolase activity. Cancer Res. 53:2227-2230 (1993).
39. Pizzorno, G., B. A. Moroson, A. R. Cashmore, O. Russello, J. R. Mayer, J. Gallivan, M. A. Bunni, D. G. Priest, and G. P. Beardsley. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. Cancer Res. 55:566-573 (1995).
40. Whitehead, V. M., D. S. Rosenblatt, M. J. Vuchich, J. J. Shuster, A. Witte, and D. Beaulieu. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis. Blood 76:44-49 (1990).
41. Yao, R., E. Schneider, T. J. Ryan, and J. Galivan. Human γ-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro. Proc. Natl. Acad. Sci. USA 93:10134-10138 (1996).